Y.S. Chae

770 total citations
41 papers, 412 citations indexed

About

Y.S. Chae is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Y.S. Chae has authored 41 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Y.S. Chae's work include Colorectal Cancer Treatments and Studies (7 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Y.S. Chae is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Y.S. Chae collaborates with scholars based in South Korea, Japan and France. Y.S. Chae's co-authors include Sang Kyun Sohn, J G Kim, Joon Ho Moon, Ho Young Chung, Deok‐Hwan Yang, Hyung Jun Kim, Joo Seop Chung, J. Jack Lee, Gabriel Yan and Jin Ho Baek and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Y.S. Chae

36 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Y.S. Chae South Korea	11	194	121	120	120	67	41	412
Jacques Olivier Bay France	12	201 1.0×	203 1.7×	116 1.0×	115 1.0×	80 1.2×	30	474
Dae Ro Choi South Korea	14	167 0.9×	157 1.3×	98 0.8×	52 0.4×	73 1.1×	43	468
Luciano Wannesson Switzerland	14	235 1.2×	174 1.4×	112 0.9×	41 0.3×	67 1.0×	31	440
PM Parikh India	10	117 0.6×	120 1.0×	70 0.6×	113 0.9×	26 0.4×	42	334
Carmelo Bengala Italy	9	176 0.9×	54 0.4×	55 0.5×	103 0.9×	63 0.9×	19	320
R. Blanco Spain	9	282 1.5×	227 1.9×	47 0.4×	170 1.4×	44 0.7×	12	511
Michael Paulussen Germany	8	165 0.9×	234 1.9×	63 0.5×	104 0.9×	29 0.4×	14	460
Jeffrey Jacobsen United States	7	165 0.9×	74 0.6×	101 0.8×	206 1.7×	39 0.6×	10	502
Mohammed Shaik United States	8	139 0.7×	54 0.4×	56 0.5×	188 1.6×	39 0.6×	20	393
S. Giralt United States	5	218 1.1×	50 0.4×	57 0.5×	325 2.7×	93 1.4×	18	486

Countries citing papers authored by Y.S. Chae

Since Specialization

Citations

This map shows the geographic impact of Y.S. Chae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y.S. Chae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y.S. Chae more than expected).

Fields of papers citing papers by Y.S. Chae

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y.S. Chae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y.S. Chae. The network helps show where Y.S. Chae may publish in the future.

Co-authorship network of co-authors of Y.S. Chae

This figure shows the co-authorship network connecting the top 25 collaborators of Y.S. Chae. A scholar is included among the top collaborators of Y.S. Chae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y.S. Chae. Y.S. Chae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chae, Y.S., et al.. (2025). Development of a stable fixed-dose combination of Montelukast Sodium and Levocetirizine Dihydrochloride using multi-layering API coating technology. International Journal of Pharmaceutics. 675. 125527–125527.

Ueno, Naoto T., Naoki Niikura, Tetsuro Yamashita, et al.. (2024). 432P Exploratory biomarker analysis of trastuzumab deruxtecan versus treatment of physician’s choice in HER2-low, hormone receptor–positive metastatic breast cancer in DESTINY-Breast04. Annals of Oncology. 35. S401–S402. 6 indexed citations

Lee, Jeeyeon, Jin Hyang Jung, Wan Wook Kim, et al.. (2022). Comparative Study Between Radioisotope Uptake and Fluorescence Intensity of Indocyanine Green for Sentinel Lymph Node Biopsy in Breast Cancer. Journal of Breast Cancer. 25(3). 244–244. 7 indexed citations

Im, S.-A., Kyung Hae Jung, Joohyuk Sohn, et al.. (2021). Potential role of CMPK1, SLC29A1, and TLE4 polymorphisms in gemcitabine-based chemotherapy in HER2-negative metastatic breast cancer patients: pharmacogenetic study results from the prospective randomized phase II study of eribulin plus gemcitabine versus paclitaxel plus gemcitabine (KCSG-BR-13-11). ESMO Open. 6(5). 100236–100236. 2 indexed citations

Kim, S-B., Bhumsuk Keam, Seong Hoon Shin, et al.. (2020). 928P Phase I dose-expansion (part II) study of ISU104 (a novel anti-ErbB3 monoclonal antibody) alone and combination with cetuximab (CET), in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Annals of Oncology. 31. S667–S668. 3 indexed citations

Chae, Y.S., et al.. (2020). Clinical Outcome of Breast Cancer Patients on Chemotherapy during the COVID-19 Pandemic in South Korea. Clinical Oncology. 33(1). e85–e86.

Jung, Jae‐Chang, et al.. (2016). The role of preoperative breast magnetic resonance (MR) imaging for surgical decision in patients with triple-negative breast cancer. Annals of Oncology. 27. vi48–vi48.

Kang, Byung Woog, et al.. (2015). 173P Impact of genetic variation in microRNA binding site on susceptibility to colorectal cancer. Annals of Oncology. 26. ix42–ix42. 1 indexed citations

Chae, Y.S., Sang Kyun Sohn, Joon Ho Moon, et al.. (2009). IVS10+12A>G polymorphism in hMSH2 gene associated with prognosis for patients with colorectal cancer. Annals of Oncology. 21(3). 525–529. 9 indexed citations

10.

Chae, Y.S., et al.. (2009). Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients. Bone Marrow Transplantation. 44(1). 35–41. 27 indexed citations

11.

Moon, Joon Ho, et al.. (2009). Clinical Significance of Autoantibody Expression in Allogeneic Stem-Cell Recipients. Transplantation. 88(2). 242–250. 10 indexed citations

12.

Kim, J G, Sang Kyun Sohn, Y.S. Chae, et al.. (2008). Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group. British Journal of Cancer. 98(3). 542–546. 20 indexed citations

13.

Kim, J G, S.K. Sohn, Y.S. Chae, et al.. (2007). Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma. Bone Marrow Transplantation. 40(10). 919–924. 25 indexed citations

14.

Sohn, Sang Kyun, et al.. (2007). Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer. Annals of Oncology. 18(6). 1030–1036. 64 indexed citations

15.

Chae, Y.S., Sang Kyun Sohn, J G Kim, et al.. (2007). New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2. Bone Marrow Transplantation. 40(6). 541–547. 57 indexed citations

16.

Chae, Y.S., et al.. (2007). Vascular endothelial growth factor gene polymorphisms and risk of colorectal cancer. Journal of Clinical Oncology. 25(18_suppl). 4123–4123. 1 indexed citations

17.

Kim, J G, Y.S. Chae, D H Kim, et al.. (2006). Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer. British Journal of Cancer. 94(10). 1407–1411. 23 indexed citations

18.

Sohn, S.K., et al.. (2005). Effectiveness of Transdermal Fentanyl Patch for Treatment of Acute Pain Due to Oral Mucositis in Patients Receiving Stem Cell Transplantation. Transplantation Proceedings. 37(10). 4488–4491. 19 indexed citations

19.

Chae, Y.S., et al.. (2003). Clinical Outcomes according to Transplanted CD34＋ Cell Dose in Allogeneic Peripheral Blood Stem Cell Transplantation. Blood Research. 38(1). 24–31. 3 indexed citations

20.

Kim, Dong‐Hyun, et al.. (2001). Prophylactic growth factor‐primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high‐risk hematologic malignancies. Cancer. 94(1). 18–24. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact